Skip to main content

Table 3 Distribution of relevant factors in female patients according to clinical stage

From: The development and validation of oral cancer staging using administrative health data

Female

  

Stage I versus II-IV

Stage I-II versus III-IV

Stage I-III versus IV

  

Stage I

 

Stage I-II

 

Stage I-III

 
  

N

%

P-value

N

%

P-value

N

%

P-value

Age

   

0.2566

  

0.4916

  

0.4026

 

20-44

6

54.55

 

6

54.55

 

8

72.73

 
 

45-64

10

31.25

 

11

34.38

 

16

50.00

 
 

> = 65

8

27.59

 

11

37.93

 

15

51.72

 

Site

   

0.0015

  

<.0001

  

0.0005

 

Lip

2

50.00

 

3

75.00

 

3

75.00

 
 

Tongue

16

59.26

 

19

70.37

 

23

85.19

 
 

Gingiva

1

12.50

 

1

12.50

 

2

25.00

 
 

Floor of mouth

2

50.00

 

2

50.00

 

2

50.00

 
 

Others

3

10.34

 

3

10.34

 

9

31.03

 

Treatment

          
 

S

17

60.71

 

20

71.43

 

24

85.71

 
 

RT

0

0.00

 

0

0.00

 

0

0.00

 
 

CT

0

0.00

 

0

0.00

 

3

15.79

 
 

S + RT

4

57.14

 

4

57.14

 

6

85.71

 
 

S + CT

2

18.18

 

3

27.27

 

5

45.45

 
 

RT + CT

1

25.00

 

1

25.00

 

1

25.00

 
 

S + RT + CT

0

0.00

 

0

0.00

 

0

0.00

 
  1. S: surgery; R: radiation; C: chemotherapy.